VISATHERA RESEARCH PRIVATE LIMITED

In their own words

1. To research, develop, and commercialize novel therapeutics derived from natural products, marine bioactives, and synthetic analogues aimed at modulating or inhibiting key enzyme targets involved in human diseases. 2. To develop hybrid pharmacophore models integrating multi-omics data (genomics, proteomics, metabolomics, etc.) for identifying and optimizing lead molecules for precision medicine. 3. To establish a translational R&D pipeline, bridging in silico modeling → in vitro screening → in vivo validation, enabling the development of affordable, high-efficacy therapeutic agents. 4. To innovate and manufacture affordable precision medicines, with a focus on diseases with high unmet clinical needs, using Indian scientific capabilities, biodiversity, and indigenous innovation. 5. To establish collaborations with academic institutions, biotechnology companies, and clinical research organizations for joint development, clinical translation, and commercialization of bioactive compounds and analogues

Written by the company on its public Startup India profile. Not verified by us.